Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience.
about
Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable)An orthotopic lung tumor model for image-guided microirradiation in ratsAre three doses of stereotactic ablative radiotherapy (SABR) more effective than 30 doses of conventional radiotherapy?Stereotactic body radiation therapy versus no treatment for early stage non-small cell lung cancer in medically inoperable elderly patients: A National Cancer Data Base analysis.Lung tumor tracking during stereotactic radiotherapy treatment with the CyberKnife: Marker placement and early results.Toxicity profile and pharmacokinetic study of a phase I low-dose schedule-dependent radiosensitizing paclitaxel chemoradiation regimen for inoperable non-small-cell lung cancer.Advances in radiotherapy techniques and delivery for non-small cell lung cancer: benefits of intensity-modulated radiation therapy, proton therapy, and stereotactic body radiation therapy.Hypofractionated radiotherapy for lung tumors with online cone beam CT guidance and active breathing controlImage-guided radiofrequency ablation of lung neoplasm in 100 consecutive patients by a thoracic surgical serviceRadical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable).Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic reviewResveratrol enhances ionizing radiation-induced premature senescence in lung cancer cells.Clinical outcomes of CyberKnife stereotactic body radiotherapy for peripheral stage I non-small cell lung cancer.Extracranial stereotactic radiation delivery: expansion of technology beyond the brain.Advantages of CyberKnife for inoperable stage I peripheral non-small-cell lung cancer compared to three-dimensional conformal radiotherapy.SBRT in operable early stage lung cancer patients.Hypofractionated stereotactic radiotherapy for primary and secondary intrapulmonary tumors: first results of a phase I/II study.Combined modality treatment of non-small-cell lung cancer.Stereotactic radiotherapy for early stage non-small cell lung cancerThe effect of radiation dose and chemotherapy on overall survival in 237 patients with Stage III non-small-cell lung cancer.Image-guided radiofrequency ablation for the treatment of early-stage non-small cell lung neoplasm in high-risk patients.LungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a clinical perspectiveDefinitive radiotherapy alone over 60 Gy for patients unfit for combined treatment to stage II-III non-small cell lung cancer: retrospective analysis.Dosimetric evaluation of the feasibility of stereotactic body radiotherapy for primary lung cancer with lobe-specific selective elective nodal irradiationStereotactic body radiation therapy for early-stage non-small-cell lung cancer.Radiofrequency ablation of pulmonary tumours: current status.Effective Rat Lung Tumor Model for Stereotactic Body Radiation TherapyRadiofrequency ablation for the treatment of lung neoplasm.Charged particle radiotherapy at the Hyogo Ion Beam Medical Center: Characteristics, technology and clinical resultsDefinition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancer.EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts' opinion for the treatment of non-small-cell lung cancer in an elderly population.Treatment options for stage I non-small-cell lung carcinoma patients not suitable for lobectomy.Thermal ablation of lung tumors.Treatment: Radiation Therapy.Activation of p53 with Nutlin-3a radiosensitizes lung cancer cells via enhancing radiation-induced premature senescence.What is the current status of Stereotactic body radiotherapy for stage I non-small cell lung cancer?Emerging Therapies for Stage III Non-Small Cell Lung Cancer: Stereotactic Body Radiation Therapy and Immunotherapy.A millimeter miss is as good as a thousand miles: The role of accurate target localization in lung stereotactic body radiation therapy.Stereotactic body radiation therapy as a derivative of stereotactic radiosurgery: clinically independent but with enduring common themes.Short- and long-term results of lung resection for cancer in octogenarians.
P2860
Q24187481-1778C6B6-702E-42D6-B46D-075477932E2CQ24595548-4DB8A419-C02A-4A56-8D5F-EB5AEA0AC37BQ26823670-3A918CA0-B2A7-4D4A-8B91-BA8113C8EDEEQ30992150-E05ED1F0-4636-4A25-A7FD-9AF5175456D6Q33257945-28410519-0F76-4DEC-AAFA-CAEA949F9194Q33378092-C6862521-8F39-4916-9D03-53DAAD5081D5Q33645619-AC61263A-7D01-4935-ABF6-DEB66CF09848Q33729123-DB00E76A-6A9F-4C6B-8926-CB49BAD2522FQ34066609-1DD23829-6470-4C3A-A742-CC52F59653D8Q34202691-4EF7B4BA-A45A-4424-89A4-7A85D8F0973BQ34312788-EF2761D3-EE5E-45DD-B1C3-BD883A300F3BQ34656775-9B9A5CFC-08B8-4C9C-8F10-069FBD31B7A4Q35033807-9BDA17E0-FC1B-4099-9ED6-387F87AA805FQ35101606-AA017622-5753-4EA8-8275-C125C351D1E6Q35180015-FCB5C9FC-28E5-4ABF-B90C-1DD99661A735Q35200592-007B2DD1-C76D-4DC3-9DB0-5C52C6112BE7Q35599955-A8124D62-731B-4406-8372-D8F038B5DAE3Q35627621-DD7F340B-5EA4-4962-870D-692D6C83E0ADQ35824255-60C1BAE6-5994-4E7C-AC0D-D2EE0C324A96Q36054729-6471936C-5C38-4224-B34D-7662CDE0257BQ36227404-DAA8BF01-4379-4C7D-BEA3-D8DE89BA38BFQ36235727-0D6F389E-BE18-475C-8F9F-2C076DA103F2Q36344205-AE699E60-8FB9-4EEC-A987-F9F7418E1D5FQ36451644-EC474B2D-0609-4FD0-A564-AAF5EFD31AC5Q37038910-6F1DAA61-73B4-4041-8F50-C10A4D2B3EE1Q37106830-2C890E7D-F3FC-49E8-B388-B3A3882A5542Q37139059-FFEB2B58-A754-4BB1-A1DE-8F3E7291DA24Q37273769-7D2B1B92-2B93-48CD-B05D-412B7E8BAEEBQ37373369-03006E13-BBE3-45D5-8531-0A82C5F6B2ACQ37468265-78BB05EA-120B-4FFD-B747-108DB388D1C7Q37589341-82D67F3B-A0D7-4A97-9996-2EC0A2534354Q37614582-A91D101B-65B3-47A1-953F-C5BB502C9369Q37850116-FD08B4E0-2BFB-46F5-BB5C-341B8E5D1B4DQ38930349-35A95BC0-7D8B-412A-922F-C2C82AAE66CBQ39150645-DEBFBC3E-FDD8-4E49-8568-4A9057C48BE2Q40342856-969C5259-32C5-40AF-AE90-9F6439E2E5B1Q41475564-8B9E3DDD-59FE-44CC-BC63-D7D7F7537BEBQ41781300-DB123C82-613F-4D09-9CF7-D38E37010FB7Q42857993-168CC88B-80F1-4EC6-AC65-FDF6323C2EFDQ43741577-46FAE0DB-7052-4B46-9B6E-E2E00B0440FB
P2860
Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Radiotherapy alone for medical ...... g cancer: the Duke experience.
@en
type
label
Radiotherapy alone for medical ...... g cancer: the Duke experience.
@en
prefLabel
Radiotherapy alone for medical ...... g cancer: the Duke experience.
@en
P2093
P1476
Radiotherapy alone for medical ...... g cancer: the Duke experience.
@en
P2093
Anscher MS
Jamieson TA
Prosnitz LR
P304
P356
10.1016/S0360-3016(97)00589-0
P407
P577
1998-01-01T00:00:00Z